This site uses cookies in order to provide a higher level of service to our customers. For more information on how we use cookies, please see our Privacy Policy. If you agree to the use of cookies, please click “OK”.

OK

COMPANY
IR
- Investor Relations
- To our shareholders and prospective investors
- JAST at a glance
- Financial Highlights
- Stock-related Information
- Shareholder Meeting Materials
- IR Library
- Financial Reports
- Timely Disclosure
- Annual Securities Report
- Shareholder Meeting Materials
- Timely Disclosure
- Financial Results Briefing Materials
- Annual Securities Report
- Disclosure Policy
Contact Us

JP
EN

INVESTOR RELATIONS

HOME
IR情報(EN)
Novo Nordisk Pharma and Japan System Techniques Launch Joint Initiative for Increasing Obesity Disease Awareness

Timely Disclosure

Fiscal year ended Mar. 31, 2026

2025.10.17

Novo Nordisk Pharma and Japan System Techniques Launch Joint Initiative for Increasing Obesity Disease Awareness

IR

Investor Relations
To our shareholders and prospective investors
JAST at a glance
Financial Highlights
Stock-related Information
Shareholder Meeting Materials
IR Library
Financial Reports
Timely Disclosure
Annual Securities Report
Financial Results Briefing Materials
Disclosure Policy

CONTACT

COMPANY
IR
- Investor Relations
- To our shareholders and prospective investors
- JAST at a glance
- Financial Highlights
- Stock-related Information
- Shareholder Meeting Materials
- IR Library
- Financial Reports
- Timely Disclosure
- Annual Securities Report
- Financial Results Briefing Materials
- Disclosure Policy

Contact Us
About this site
Privacy Policy

© Japan System Techniques Co., Ltd.